{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:47:06Z","timestamp":1793119626973,"version":"4.5.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012500","name":"Complex Engineering Systems Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vaccine.2025.127591","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T06:14:12Z","timestamp":1755238452000},"page":"127591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Safety of timely immunization with nirsevimab in hospitalized preterm infants"],"prefix":"10.1016","volume":"63","author":[{"given":"Giannina","family":"Izquierdo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Villena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javiera","family":"Albornoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Hueichao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2025.127591_bb0005","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1542\/neo.21-8-e535","article-title":"Preventive strategies for respiratory syncytial virus infection in young infants","volume":"21","author":"Taveras","year":"2020","journal-title":"Neoreviews"},{"issue":"25","key":"10.1016\/j.vaccine.2025.127591_bb0010","first-page":"00233","article-title":"Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study","volume":"S1473-3099","author":"Torres","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127591_bb0015","series-title":"Guidelines for the administration of respiratory syncytial virus (RSV) monoclonal antibody Nirsevimab Department of Immunization, Division of Disease Prevention and Control, Under-Secretariat of Public Health, Ministry of Health, Chile","author":"Technical Operational","year":"2024"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127591_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127591_bb0025","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMc2112186","article-title":"Safety of Nirsevimab for RSV in infants with heart or lung disease or prematurity","volume":"386","author":"Domachowske","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127591_bb0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127591_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1056\/NEJMoa2314885","article-title":"Nirsevimab and hospitalization for RSV bronchiolitis","volume":"391","author":"Assad","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127591_bb0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/pathogens13060503","article-title":"Comprehensive summary of safety data on Nirsevimab in infants and children from all pivotal randomized clinical trials","volume":"13","author":"Mankad","year":"2024","journal-title":"Pathogens"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127591_bb0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/vaccines12050549","article-title":"Safety and efficacy of Nirsevimab in a universal prevention program of respiratory syncytial virus bronchiolitis in newborns and infants in the first year of life in the Valle D\u2019aosta region, Italy, in the 2023-2024 epidemic season","volume":"12","author":"Consolati","year":"2024","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127591_bb0050","volume":"14","author":"Pergolizzi","year":"2022","journal-title":"Treating Apnea Prematurity Cureus"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127591_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jamapediatrics.2024.5311","article-title":"Apnea after 2-month vaccinations in hospitalized preterm infants: a randomized clinical trial","volume":"179","author":"Greenberg","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127591_bb0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s12887-021-03053-9","article-title":"An outbreak of RSV infections in a neonatology clinic during the RSV-season","volume":"21","author":"Vakrilova","year":"2021","journal-title":"BMC Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25008886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25008886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T03:52:05Z","timestamp":1765857125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25008886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":12,"alternative-id":["S0264410X25008886"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127591","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of timely immunization with nirsevimab in hospitalized preterm infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127591"}}